MBX Biosciences Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Peter Hawryluk
Chief executive officer
US$4.9m
Total compensation
| CEO salary percentage | 8.6% |
| CEO tenure | no data |
| CEO ownership | 2.6% |
| Management average tenure | less than a year |
| Board average tenure | 2.1yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$47m |
| Mar 31 2024 | n/a | n/a | -US$39m |
| Dec 31 2023 | US$5m | US$420k | -US$33m |
Compensation vs Market: Peter's total compensation ($USD4.86M) is above average for companies of similar size in the US market ($USD3.24M).
Compensation vs Earnings: Insufficient data to compare Peter's compensation with company performance.
CEO
Peter Hawryluk (55 yo)
no data
Tenure
US$4,862,064
Compensation
Mr. P. Kent Hawryluk, MBA, served as Chief Business Officer of Avidity Biosciences LLC from January 2013 to December 19, 2019. Mr. Hawryluk is a Partner at Twilight Venture Partners, LLC. He co-founded and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | no data | US$4.86m | 2.64% $ 21.1m | |
| Chief Financial Officer | 2.4yrs | US$1.05m | 0% $ 0 | |
| Chief Scientific Officer | 1.2yrs | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
1.0yrs
Average Tenure
57yo
Average Age
Experienced Management: MBX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | no data | US$4.86m | 2.64% $ 21.1m | |
| Independent Director | 4.2yrs | no data | no data | |
| Independent Director | 4.2yrs | no data | no data | |
| Independent Director | 3.9yrs | no data | 0.31% $ 2.4m | |
| Independent Director | 4.2yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 2.4yrs | no data | 0.050% $ 398.4k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 1.8yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
2.1yrs
Average Tenure
64yo
Average Age
Experienced Board: MBX's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.